Drug: vincristine Quarter: 2016Q3
Total Records: 1,179 Number of Pages: 59
| DRUGNAME | PT | EventCount |
|---|---|---|
| VINCRISTINE SULFATE. | Gastrointestinal haemorrhage | 2 |
| VINCRISTINE SULFATE. | Haemodynamic instability | 2 |
| VINCRISTINE SULFATE. | Heart rate increased | 2 |
| VINCRISTINE SULFATE. | Heart sounds abnormal | 2 |
| VINCRISTINE SULFATE. | Hepatic congestion | 2 |
| VINCRISTINE SULFATE. | Hepatic function abnormal | 2 |
| VINCRISTINE SULFATE. | Hepatosplenic candidiasis | 2 |
| VINCRISTINE SULFATE. | Hepatosplenomegaly | 2 |
| VINCRISTINE SULFATE. | Hyperglycaemia | 2 |
| VINCRISTINE SULFATE. | Hypokalaemia | 2 |
| VINCRISTINE SULFATE. | Inappropriate antidiuretic hormone secretion | 2 |
| VINCRISTINE SULFATE. | Infusion related reaction | 2 |
| VINCRISTINE SULFATE. | Intracranial venous sinus thrombosis | 2 |
| VINCRISTINE SULFATE. | Ischaemic pancreatitis | 2 |
| VINCRISTINE SULFATE. | Leukaemia recurrent | 2 |
| VINCRISTINE SULFATE. | Lower respiratory tract infection | 2 |
| VINCRISTINE SULFATE. | Maternal exposure during pregnancy | 2 |
| VINCRISTINE SULFATE. | Metastases to central nervous system | 2 |
| VINCRISTINE SULFATE. | Mucormycosis | 2 |
| VINCRISTINE SULFATE. | Mucous membrane disorder | 2 |
Total Records: 1,179 Number of Pages: 59